2024 annual financial data
Pliant Therapeutics 2024 Operating margin
Pliant Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -228,365,000 USD and net income was -210,304,000 USD.
Operating cash flow was -155,503,000 USD.
Get free Pliant Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -228,365,000 USD
- Net income
- -210,304,000 USD
- Operating cash flow
- -155,503,000 USD